|
Volumn 9, Issue 4, 2001, Pages 273-278
|
An alpha1-antitrypsin enhancer polymorphism is a genetic modifier of pulmonary outcome in cystic fibrosis
a b a a b a b |
Author keywords
1 Antitrypsin enhancer polymorphism; Cystic fibrosis; Pulmonary outcome
|
Indexed keywords
ALPHA 1 ANTITRYPSIN;
DNA;
CFTR PROTEIN, HUMAN;
TRANSMEMBRANE CONDUCTANCE REGULATOR;
ADOLESCENT;
ADULT;
ALLELE;
ARTICLE;
BACTERIAL COLONIZATION;
CONTROLLED STUDY;
CYSTIC FIBROSIS;
DISEASE EXACERBATION;
DISEASE SEVERITY;
ENHANCER REGION;
FEMALE;
GENETIC POLYMORPHISM;
GENOTYPE;
HUMAN;
INFECTION;
LUNG DISEASE;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
PROGNOSIS;
PSEUDOMONAS AERUGINOSA;
RESPIRATORY FUNCTION;
THORAX RADIOGRAPHY;
CASE CONTROL STUDY;
GENETICS;
LUNG;
METABOLISM;
PATHOPHYSIOLOGY;
PROSPECTIVE STUDY;
RADIOGRAPHY;
BACTERIA (MICROORGANISMS);
PSEUDOMONAS;
PSEUDOMONAS AERUGINOSA;
ADOLESCENT;
ADULT;
ALPHA 1-ANTITRYPSIN;
CASE-CONTROL STUDIES;
CYSTIC FIBROSIS;
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;
ENHANCER ELEMENTS (GENETICS);
FEMALE;
HUMANS;
LUNG;
MALE;
POLYMORPHISM, GENETIC;
PROGNOSIS;
PROSPECTIVE STUDIES;
|
EID: 0034744674
PISSN: 10184813
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.ejhg.5200623 Document Type: Article |
Times cited : (39)
|
References (18)
|